Chul Kim: In-depth review of BRAF mutant NSCLC by Dr. Marcelo Negrao at Texas Lung 24 Conference
Chul Kim, Thoracic Medical Oncologist at Georgetown University, shared a post on X:
“In-depth review of BRAF mutant NSCLC by Dr. Marcelo Negrao.
Now we have two FDA-approved combination TKI therapies.
Highlighted was ongoing work to understand the sequencing of treatment and incorporation of IO in the treatment algorithm.”
Source: Chul Kim/X
About OncoDaily
OncoDaily was founded in 2023. It is a US-based oncology media platform, which features the latest news, insights, and patient stories from the world of oncology. Within a short period of time it became one of the leading oncology media platforms globally.
OncoDaily gathers content from various sources, including social media posts from renowned oncologists from all over the world, news from oncology societies and cancer centers, patient and survivor stories, and career-related information for professionals.
The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we”.
